Skip to main content

Month: June 2021

Metacrine and Its Partners to Present Data at the EASL International Liver Congress™ 2021

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that it will present data at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2021, being held virtually from June 23-26, 2021. Data to be presented includes results from the Company’s Phase 1 trial of MET642, a farnesoid X receptor (FXR) agonist being developed for the treatment of non-alcoholic steatohepatitis (NASH), as well as one oral presentation and one poster focused on preclinical studies examining FXR agonists in rare adult and pediatric cholestatic liver diseases. The full list of Metacrine and partner presentations are listed below: Poster PO-393: MET642,...

Continue reading

REMINDER: Salarius Pharmaceuticals to Host Virtual Key Opinion Leader and Investor Event

Online Event Scheduled for Monday, June 21, 2021, at 2:00 p.m., ET Event to Spotlight Seclidemstat and Feature Experts in the Fields of Epigenetics, Sarcomas, and Hematological Cancers HOUSTON, June 17, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that it will host a virtual key opinion leader (KOL) and investor event focused on the scientific rationale and clinical development of seclidemstat, the Company’s lead drug candidate. Seclidemstat is a novel, oral, reversible inhibitor of lysine-specific histone demethylase 1 (LSD1), an enzyme that has been shown to play a key role in the development and progression of several cancers. The online...

Continue reading

Whitestone REIT Introduces “Easy Lease” Initiative Designed to Enhance Customer Experience, Increase Occupancy and Revenue in Its Texas and Arizona Properties

HOUSTON, June 17, 2021 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE:WSR) today announced that it has launched its new “Easy Lease” initiative, a technology-enabled expedited leasing process for entrepreneurial clients looking for “sign today, move in tomorrow” space. This new initiative is designed to attract a new and growing category of clients to Whitestone properties and increase 18-hour/7-day-a-week traffic. It is being implemented for select properties in Whitestone’s portfolio, and the company plans to expand it to additional properties based on clients’ needs. “Most clients find a lease to be a complicated, laborious and difficult-to-understand legal document. We’ve gone to extreme lengths to simplify it and reduce the legalese to make our Easy Lease form easy to understand, thereby increasing the confidence of making a decision...

Continue reading

Intema Provides Update on Livestream Acquisition and Concurrent Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES MONTREAL, June 17, 2021 (GLOBE NEWSWIRE) — Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF) is pleased to announce the terms of the financing being undertaken by the Corporation in connection with its previously announced proposed acquisition of all of the issued and outstanding securities of Livestream Gaming Ltd (see press release dated May 3, 2021) (the “Proposed Transaction”). Intema intends to complete a non-brokered private placement of a minimum of 20,000,000 and a maximum of 30,000,000 subscription receipts (each a “Subscription Receipt”) at a price of $0.50 per Subscription Receipt (the “Subscription Price”) for aggregate gross proceeds of a minimum of $10,000,000 and a maximum of $15,000,000 (the “Private...

Continue reading

LexaGene’s MiQLab Offers Rapid Plague Detection for Bioterrorism Threats

First-of-its-Kind for Rapidly Detecting Category A Bioterrorism Agents BEVERLY, Mass., June 17, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) a molecular diagnostics company, is pleased to announce that today, Dr. Jack Regan, CEO and Founder of LexaGene, will present at the Biothreat and Pathogen Detection Conference regarding the MiQLab™ System’s ability to detect the pathogen that causes plague. Dr. Jack Regan states, “Our MiQLab System is both open-access and designed for point-of-care use, making it a first–of–its–kind system. These unique features are critical for early point-of-care diagnoses, which improves the probability for successful biocontainment of novel pathogens. The past 18 months have highlighted how badly humanity needs advanced technologies like the MiQLab to more...

Continue reading

Bombardier Announces Expiration of Early Tender Date and Amendment for its Cash Tender Offer for Certain Outstanding Senior Notes

MONTREAL, June 17, 2021 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier” or the “Corporation”) today announced certain matters with respect to its cash tender offer previously announced on June 3 2021 (the “Tender Offer”) to purchase for cash up to US$1,000,000,000 aggregate purchase price (exclusive of Accrued Interest) (as such aggregate purchase price may be increased or decreased by the Corporation, the “Aggregate Maximum Purchase Amount”) of three series of its outstanding senior notes (collectively, the “Notes”) due 2022 and 2023 as identified in the Offer to Purchase (as defined below), subject to the Acceptance Priority Levels and the 2023 Tender Cap (as such 2023 Tender Cap may be increased or decreased by the Corporation, including the increase described herein), as applicable, and possible proration, as set forth in...

Continue reading

Nanox Announces FDA 510(k) Submission for First Version of Multi-Source Nanox.ARC

510(K) Class II FDA submission seeks clearance of the first version of company’s multi-source 3-D digital tomosynthesis system as the next step in its U.S. regulatory process NEVE ILAN, Israel, June 17, 2021 (GLOBE NEWSWIRE) — NANOX IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that the Company has submitted a 510(k) premarket notification application to the U.S. Food and Drug Administration (FDA) for the first version of its multi-source Nanox.ARC 3-D digital tomosynthesis system. “The 510(k) submission for the first version of our multi-source Nanox.ARC is an important achievement,” stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. “There exists a significant unmet medical need globally for a more accessible and cost-effective medical...

Continue reading

Ormat Signed a New Product Segment Supply Contract in Indonesia Supporting Its Backlog

Contract Award Signals Markets Reopening Post-Covid RENO, Nev., June 17, 2021 (GLOBE NEWSWIRE) — Ormat Technologies Inc. (NYSE: ORA) announced today that it has secured a new contract with Star Energy Geothermal Salak to supply products to extends the Salak geothermal field in Indonesia. The Salak geothermal field is located near Jakarta on the southwest flank of the Gunung Salak volcano and is currently contains geothermal power plant utilizing steam. The new 14 MW Salak geothermal power plant will use air-cooled Ormat Energy Converter and will allow 100% geothermal fluid reinjection which serves both to sustain the reservoir and to produce electrical power with virtually no environmental impact. Ormat is in partnership with local contractor that will provide the EPC services. The supply of the plant is expected to be completed...

Continue reading

CareDx CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit

Reg Seeto will present on technology that enables transplant patient care at the AAKP 2021 Summit SOUTH SAN FRANCISCO, Calif., June 17, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that Reg Seeto, President and CEO of CareDx, will present “Improving Access to Transplant Care: Telehealth & Technology to Enable Patients Along the Transplant Journey,” at the American Association of Kidney Patients (AAKP) 4th Annual Policy Summit, which will be held virtually on June 17, 2021. Reg Seeto will be presenting on the growing need for telehealth solutions, accelerated by the COVID-19 pandemic, that has...

Continue reading

XPO Logistics Recognized for Environmental Sustainability as a Green 75 Supply Chain Partner

GREENWICH, Conn., June 17, 2021 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics solutions, has been named a Green 75 Supply Chain Partner by Inbound Logistics magazine — marking the sixth straight year the company has been honored as an industry leader in sustainability. Malcolm Wilson, chief executive officer of XPO Logistics Europe, said, “We thank Inbound Logistics for recognizing XPO’s commitment to reducing the environmental footprint of our operations. We continue to explore innovative ways to operate as a more sustainable company, which helps our customers achieve their green objectives as well.” XPO is one of 75 companies honored by Inbound Logistics in 2021 for helping shippers maintain environmentally conscious supply chain operations. Details about the company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.